Davis-based Expanesthetics raises another $1.16 million in venture capital

Davis-based pharmaceutical company Expanesthetics Inc. has raised another $1.16 million in venture capital, according to a recent Securities and Exchange Commission filing.   The 6-year-old company is developing alternatives to general anesthetics. Expanesthetics is the sole licensee of a patented anesthetic technology originally researched through programs associated with the University of California. The latest round of investment was funded by existing shareholde rs, over half of whom are anesthesiologists…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news